Investors / Norway / Norinnova Invest
Norinnova Invest
Venture capital · Tromsø, Norway · Europe
Norinnova Invest AS is an investment fund focused on technology- and research-based growth companies in Northern Norway. The fund was established in 2007, was closed to new investments on 1 January 2013, and now only makes follow-on investments in its own portfolio.
Invests inHealthcare & BiotechFood & Agriculture
In its own wordstechnologyresearch-basedseed stageearly venturenorthern norway
Your fit with Norinnova Invest
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNorinnova Invest lists 4 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (80%) and Food & Agriculture (20%). 100% of its companies are based in Norway.
No funding round on record names Norinnova Invest yet, so the figures come from its portfolio page.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 80% | 15% |
| Food & Agriculture | 20% | 3% |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Compare Norinnova Invest head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
4 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Amicoat provides the next-generation antimicrobial technology for medical devices | Healthcare & Biotech | Portfolio page | ||
| Lytix Biopharma is developing a pipeline of oncolytic molecule therapies that treat both superficial and deep-seated tumors. | Healthcare & Biotech | Portfolio page | ||
| Pharma Holdings is developing effective drugs and treatments against respiratory viral infections | Healthcare & Biotech | Portfolio page | ||
| The company harvests and produces nutrients for humans and animals from the zooplankton species Calanus finmarchicus. | Food & AgricultureHealthcare & Biotech | Portfolio page |
About this data
site last read 12 Nov 2026- Site
- norinnovainvest.no
- Last read
- 12 Nov 2026
- Watching since
- 7 Nov 2026
- Companies checked
- 4
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Norinnova Invest's profile as data
Pull Norinnova Invest's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/norinnovainvest.no
# also
GET /v1/firms/norinnovainvest.no/portfolio
GET /v1/firms/norinnovainvest.no/coinvestors
GET /v1/firms/norinnovainvest.no/news